低分子肝素和普通肝素治疗急性肺栓塞疗效研究

目的探究低分子肝素与普通的肝素治疗急性肺栓塞的临床疗效。方法将我院2010年2月至2012年2月之间收录的68例急性肺栓塞患者随机的分为两组,A组34例患者给予低分子肝素进行治疗,而B组34例患者给予普通肝素进行治疗,观察两组治疗的临床效果。结果通过两组的患者治疗效果分析,A组和B组的患者治疗效果和不良反应发生率的比较无明显的差异(P>0.05)。结论低分子肝素与普通的肝素治疗急性肺栓塞的临床效果相似,效果明显,值得临床中应用。

Low molecular weight heparin and unfractionated heparin in the treatment of acute pulmonary embol- ism efficacy study

Objective To explore the clinical efficacy of the low molecular weight heparin and unfrac- tionated heparin in the treatment of acute pulmonary embolism. Methods Our hospital between February 2010 to February 2012, included 68 patients with acute pulmonary embolism in patients randomly divided into two groups, A group of 34 patients were treated with low molecular weight heparin for treatment, while the group B, 34 patients were given unfractionated heparin for treatment, observe the clinical effect of the treatment. Results The two groups of patients with treatment effect analysis of group A and group B patient outcomes and the in- cidence of adverse reactions was no significant difference （ P 〉 0.05 ）. Conclusion The clinical effect of the low molecular weight heparin and unfractionated heparin in the treatment of acute pulmonary embolism similar effect is obvious, worthy of clinical application.